Maryland State Retirement & Pension System Has $9.96 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Maryland State Retirement & Pension System lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,082 shares of the medical equipment provider’s stock after selling 1,293 shares during the period. Maryland State Retirement & Pension System’s holdings in Intuitive Surgical were worth $9,960,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $31,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth $33,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last quarter. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Stock Down 1.0 %

NASDAQ ISRG opened at $483.95 on Wednesday. The company’s 50 day moving average is $565.43 and its 200-day moving average is $531.90. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market cap of $172.37 billion, a P/E ratio of 75.50, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.